Paul Offit and the “Original Sin” of Autism
Counting Offit’s Millions: More on How Merck’s Rotateq Vaccine Made Paul Offit Wealthy

CDC Workshop on Autism Prevalence Feb 1 - Webinar Closed?

Webinar Workshop to Evaluate Changes in the Prevalence of the Autism Spectrum Disorders (HERE on right sidebar area.) Mark Blaxill is schedule to present at this workshop.

February 1, 2011
8:30 a.m. – 5:00 p.m.
Atlanta, GA

Webinar appears to be closed - which seems unacceptable. Every stakeholder and taxpayer should be able to attend. (register here)


Lisa @ TACA

Hi all-

TACA Georgia registered and was there.
We got the notice a few weeks back from a public list serve.

I know Mark Blaxill was there too


Cynthia Cournoyer

"Changes" in the prevalence? Another attempt at re-defining the condition to make it look like the numbers are not going up?

sneaker city

Well, of course the "room" is full, it's a virtual meeting. cough, cough, **bullshit**.

L Land

of course it is closed...what in the world is more closed than the CDC's view on autism


I decided not to go...........

I'll let Mark and the others with far more patience than I attend instead. So Mark, if you don't hear anyone yelling "BULLSH*T!" when someone from the "I <3 Using Genetics as a Scapegoat for Vaccines" crowd begins to speak, that's cause I stayed home.

Anne McElroy Dachel

It's reached capacity? Really?
I'd love to know who's attending.
Anne Dachel

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name and email address are required. Email address will not be displayed with the comment.)